Keywords: عامل ضد التهاب; perioperative medications; cardiac surgery; noncardiac surgery; beta-blockers; antiplatelet agent; statins; antihypertensives;
مقالات ISI عامل ضد التهاب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل ضد التهاب; Anticoagulant; Antiplatelet; Antithrombotic; Intracerebral hemorrhage; Intracranial hemorrhage; Subarachnoid hemorrhage; APA; Antiplatelet agent; ATM; Antithrombotic medication; ICH; Intracranial hemorrhage; INR; International normalized ratio; OAC; Oral
Keywords: عامل ضد التهاب; Stomach; Intestine; Peptic Ulcer; Small Bowel; Colon; Side Effect; Complication; APA; antiplatelet agent; ASA; low-dose aspirin; CI; confidence interval; GI; gastrointestinal; H2RA; H2 receptor antagonist; LGIB; lower gastrointestinal bleeding; NSAID; non
Keywords: عامل ضد التهاب; Warfarin; Antiplatelet agent; Acupuncture; Hemorrhage; Side effect; Safety;
Keywords: عامل ضد التهاب; Dipyridamole; Antiplatelet agent; Pleiotropic actions; Therapeutic potentials;
Keywords: عامل ضد التهاب; End-stage renal disease; Haemodialysis; Vascular access thrombosis; Thrombin generation assay; Antiplatelet agent;
Keywords: عامل ضد التهاب; acute stroke; antiplatelet agent; neurological deterioration; stroke recurrence
Preparation and characterization of solid dispersion of novel dual antiplatelet agent BF061 for oral use
Keywords: عامل ضد التهاب; Antiplatelet agent; P2Y12; Solid dispersion; BF061;
Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling
Keywords: عامل ضد التهاب; Integrin αIIbβ3; cAMP; VASPser157; Ginsenoside-Rp3; Antiplatelet agent;
La protection cardiovasculaire du patient diabétique avec maladie rénale chronique et cas particulier de l'insuffisance rénale chronique terminale du sujet âgé
Keywords: عامل ضد التهاب; Diabète; Maladie rénale chronique; Morbi-mortalité; cardiovasculaire; Glycémie; BSRA; Pression artérielle; Dyslipidémie; Antiagrégant plaquettaire; Dialyse; Traitement conservateur; Score pronostique; Concertation; Diabetes; Chronic kidney disease;
Prevention of arterial thrombosis by edoxaban, an oral factor Xa inhibitor in rats: monotherapy and in combination with antiplatelet agents
Keywords: عامل ضد التهاب; Edoxaban (PubChem CID: 25022378); Clopidogrel (PubChem CID: 115366); Aspirin (PubChem CID: 2244)Arterial thrombosis; Direct factor Xa inhibitor; Edoxaban; Antiplatelet agent; Platelet procoagulant activity; Bleeding
The management of antithrombotic agents for patients undergoing GI endoscopy
Keywords: عامل ضد التهاب; ACS; acute coronary syndrome; AF; atrial fibrillation; APA; antiplatelet agent; ASA; acetylsalicylic acid, or aspirin; CVA; cerebrovascular accident; DAPT; dual antiplatelet therapy; DVT; deep vein thrombosis; FDA; U.S. Food and Drug Administration; GP; g
Identification of 1-{2-[4-chloro-1′-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4′-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y1 antagonist as an antiplatelet ag
Keywords: عامل ضد التهاب; P2Y1 antagonist; Spiropiperidinylindolines; Antiplatelet agent
Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Outpatients With Stable Coronary Artery Disease
Keywords: عامل ضد التهاب; antiplatelet agent; coronary artery disease; major bleeding; oral anticoagulant; outcome; vitamin K antagonist; APT; antiplatelet therapy; BARC; Bleeding Academic Research Consortium; CAD; coronary artery disease; CIs; confidence intervals; eGFR; esti
Cerebral Microbleeds on T2*-Weighted Images and Hemorrhagic Transformation after Antithrombotic Therapies for Ischemic Stroke
Keywords: عامل ضد التهاب; Ischemic stroke; gradient-echo T2*-weighted sequences; microbleeds; anticoagulant; antiplatelet agent; hemorrhagic transformation
Efficacy of Cilostazol in Preventing Aspiration Pneumonia in Acute Cerebral Infarction
Keywords: عامل ضد التهاب; Pneumonia; stroke; antiplatelet agent; dysphagia
Hémorragies intracrâniennes : épidémiologie et implication des traitements antithrombotiques
Keywords: عامل ضد التهاب; anticoagulant; antiagrégantplaquettaire; antithrombotique; hémorragie intracrânienne; anticoagulant; antiplatelet agent; antithrombotic treatment; intracranial hemorrhage; AAP; antiagrégant plaquettaire; AC; anticoagulant; AC/FA; arythmie complète /
Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis
Keywords: عامل ضد التهاب; Dialysis; vascular access; antiplatelet agent; thrombosis; systematic reviews; meta-analysis;
Lack of association between serum paraoxonase-1 activity and residual platelet aggregation during dual anti-platelet therapy
Keywords: عامل ضد التهاب; PON1; paraoxonase-1; HTLase; homocysteine thiolactone hydrolase; PCI; percutaneous coronary artery intervention; CYP; cytochrome P450; BNP; brain natriuretic peptide; antiplatelet agent; platelet pharmacology; coronary syndrome;
Antiplatelet Agents Are Risk Factors for Cerebellar Hemorrhage in Patients With Primary Intracerebral Hemorrhage
Keywords: عامل ضد التهاب; Antiplatelet agent; cerebral hemorrhage; cerebellar hemorrhage
Antiplatelet effects of Spatholobus suberectus via inhibition of the glycoprotein IIb/IIIa receptor
Keywords: عامل ضد التهاب; Spatholobus suberectus; Platelet aggregation; Antiplatelet agent; Glycoprotein IIb/IIIa; Thromboxane A2;
Glybenclamide: An antidiabetic with in vivo antithrombotic activity
Keywords: عامل ضد التهاب; Thromboxane A2 receptor; Platelet activation; Antiplatelet agent; Antithrombotic agent; Antagonist; Drug repurposing; Thrombosis
Emergency Reversal of Antiplatelet Agents in Patients Presenting with an Intracranial Hemorrhage: A Clinical Review
Keywords: عامل ضد التهاب; Antiplatelet agent; Aspirin; Clopidogrel; Coagulopathy; Intracranial hemorrhage; Platelet transfusion; Stroke; TraumaASA, Aspirin (acetylsalicylic acid); COX-1, Cyclooxygenase-1; ICH, Intracranial hemorrhage; NSAIDs, Nonsteroidal anti-inflammatory drugs;
Effects of prasugrel, a novel P2Y12 inhibitor, in rat models of cerebral and peripheral artery occlusive diseases
Keywords: عامل ضد التهاب; P2Y12 antagonist; ADP; Platelet aggregation; Antiplatelet agent; Thienopyridine; Stroke; Peripheral arterial occlusive disease
Stents coronariens et anesthésie : il est temps d'avoir des données nationales
Keywords: عامل ضد التهاب; Endoprothèse coronarienne; Stent métallique; Stent pharmaco-actif; Infarctus; Antiagrégant plaquettaireCoronary stent; Bare metal stent; Drug eluting stent; Myocardial infarction; Stent thrombosis; Antiplatelet agent
BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2αin vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodents
Keywords: عامل ضد التهاب; Thromboxane A2; Antiplatelet agent; Isoprostanes
Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity
Keywords: عامل ضد التهاب; Antiplatelet agent; Brazilin derivative; Calcium mobilization; Platelet aggregation
2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets
Keywords: عامل ضد التهاب; Antiplatelet agent; Thrombin; Thromboxane A2;
Antiplatelet activity of BRX-018, (6aS,cis)-Malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester
Keywords: عامل ضد التهاب; Antiplatelet agent; Brazilin derivative; Platelet aggregation; Thromboxane A2; Phospholipase A2;